Sarah Brothers
About Sarah Brothers
Sarah Brothers is the Director of Clinical Program Management at Akero Therapeutics, where she has worked since 2023. She has extensive experience in clinical program management, having held positions at notable companies such as Genentech, Gilead Sciences, and Stanford University Medical School.
Work at Akero Therapeutics
Sarah Brothers currently serves as the Director of Clinical Program Management at Akero Therapeutics. She has held this position since 2023, contributing to the management and oversight of clinical programs within the organization. Her role involves coordinating clinical trials and ensuring compliance with regulatory standards.
Previous Experience in Clinical Program Management
Prior to her current role, Sarah Brothers worked at Gilead Sciences as Associate Director from 2019 to 2023. She also served as Clinical Program Manager at Gilead Sciences from 2016 to 2019. Her experience at Genentech includes positions as Global Studies Leader from 2015 to 2016 and Global Studies Manager from 2012 to 2015, where she was involved in managing global clinical studies.
Clinical Research Background
Sarah Brothers has a solid foundation in clinical research, having worked in various roles since 2000. She was a Research Associate at Stanford University Medical School from 2000 to 2002. Her experience includes positions as Sr. Clinical Research Associate at Geron in 2009, Nektar Therapeutics from 2010 to 2011, and Jazz Pharmaceuticals from 2007 to 2008.
Education and Expertise
Sarah Brothers earned her Bachelor's degree in English from the University of California, Davis. Additionally, she studied Clinical Trial Design and Management at the University of California, Santa Cruz. This educational background supports her expertise in clinical program management and research.